Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

353
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
353
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

112
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
112

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety.

bioRxiv : the preprint server for biology·2026
Same author

Human Multi-Organ-on-a-Chip Platforms for Next-Generation Drug Delivery Strategies.

Theranostics·2026
Same author

Development of bicistronic plasmids and fusion proteins for clinical translation of tumor immune reprogramming.

Molecular therapy. Advances·2026
Same author

Base editing and nanoparticle transfection of airway cell types essential for treatment of cystic fibrosis.

JCI insight·2026
Same author

Upping the "Plex": Whole Slide, Automated 14-Color Multiplex Immunofluorescence Staining of the Tumor Microenvironment in Paraffin-Embedded Tissue.

Laboratory investigation; a journal of technical methods and pathology·2026
Same author

Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion.

Science advances·2026

Related Experiment Video

Updated: Apr 5, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.3K

Biomimetic particles as therapeutics.

Randall A Meyer1, Joel C Sunshine1, Jordan J Green1,2

  • 1Department of Biomedical Engineering, Translational Tissue Engineering Center, and Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith 5017, Baltimore MD, 21231, USA.

Trends in Biotechnology
|August 17, 2015
PubMed
Summary

Novel nanoparticle and microparticle therapeutics are advancing with biomimetic features. These engineered particles mimic natural structures, enhancing their interaction with biological systems for improved therapeutic potency and human health benefits.

Keywords:
biomaterialbiomimeticdrug deliverymicro/nanoparticle

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

10.0K

Related Experiment Videos

Last Updated: Apr 5, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.3K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

10.0K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery

Background:

  • Recent advancements in nanoparticle and microparticle therapeutics.
  • Emerging trend of incorporating biomimetic features into synthetic constructs.
  • Need for improved therapeutic particle interaction with biological systems.

Purpose of the Study:

  • To explore the development of biomimetic nanoparticle and microparticle therapeutics.
  • To highlight the advantages of mimicking natural biological structures.
  • To discuss the impact of biomimetic features on therapeutic potency.

Main Methods:

  • Engineering particle cores with controlled size, shape, and material consistency to mimic natural cells and viruses.
  • Advancing biomimetic surface functionalization using bio-inspired artificial and naturally derived cell membranes.
  • Integrating biomimetic strategies into therapeutic particle design.

Main Results:

  • Successful generation of particle cores that effectively mimic natural cells and viruses.
  • Significant progress in biomimetic surface functionalization of therapeutic particles.
  • Demonstrated potential for enhanced therapeutic particle performance.

Conclusions:

  • Biomimetic technologies represent a significant paradigm shift in therapeutic particle development.
  • Mimicking natural biological structures enhances particle performance and therapeutic efficacy.
  • These advancements hold promise for substantial benefits to human health through more potent therapeutics.